Pacs Group Inc (PACS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pacs Group Inc   (NYSE: PACS)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Pacs Group Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pacs Group Inc's ROI in the second quarter of 2026?
Pacs Group Inc achieved a return on average invested assets (ROI) of 5.86 % in its second quarter of 2026, this is above PACS's average return on investment of 4.03%.
Pacs Group Inc s investments during the 12 months ending in the second quarter of 2026 are valued at $4 billion

Despite the deterioration in its net income, company has improved ROI compared to the first quarter of 2026.

Within the Healthcare sector 7 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1180 to 1423.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 54.58 % 107 % 133.13 % 95.95 % 99.48 %
Y / Y Net Income Change TTM 104.28 % 398.41 % 832.82 % - -
Investment (TTM) in Millions 4,606 4,595 4,733 4,435 4,341
Return On Investment (TTM) 5.86 % 5.39 % 4.28 % 4.55 % 4.43 %
PACS's Overall Ranking # 1423 # 1180 # 1230 # 0 # 0
Seq. Investment Change TTM 1.47 % 1.13 % 21.38 % 24.11 % 35.88 %
Seq. Net Income Change TTM 10.41 % 27.31 % 14.06 % 27.42 % 169.39 %
Net Income (TTM) in Millions 269 244 191 168 132

PACS Company Profile >> Back to PACS Roi Comparisons >> See Annual PACS Return On Investment



Return On Investment PACS's Ranking
Within: No.
Industry # 1
Sector # 8
Overall # 1423

Return On Investment Statistics
High Average Low
5.43 %
4.03 %
2.02 %
(Mar 31 2026)   (Mar 31 2025)







Financial Statements
Pacs Group Inc's II. Quarter Investments $ 4,606 Millions PACS's Balance sheet
Pacs Group Inc's II. Quarter Income $ 76 Millions Quarterly PACS's Income Statement
PACS's Income by Division See PACS's Income by Division


PACS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2022)
2024


Total Investments in Millions 4,588 1,428 0 0 0
Y / Y Investment Growth 221.28 % - - - -
Net Income in Millions 191 150 0 0 0
Y / Y Net Income Growth 27.22 % - - - -
Annual Return On Investment 4.17 % 10.54 % - - -


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 4.17 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PACS's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PACS's Competitors
Subscribers only: Roi for Pacs Group Inc's Suppliers
Subscribers only: Return On Investment for PACS's Customers

Other Ratios
PACS's Roa PACS's Inventory Turnover Ratio PACS's Growth Rates PACS's Dividend Statistics
PACS's Profitability Ratios PACS's Asset Turnover Ratio PACS's Dividend Growth
PACS's Roe PACS's Valuation Ratios PACS's Financial Strength Ratios PACS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %
Progyny Inc   15.25 %
Biolife Solutions Inc   14.83 %
Sbc Medical Group Holdings Incorporated  14.78 %
Spero Therapeutics Inc   14.54 %
Insulet Corporation  14.30 %
Alpha Pro Tech Ltd   13.80 %
Bristol myers Squibb Company  13.58 %
Transmedics Group Inc   13.46 %
Strata Critical Medical Inc   13.34 %
Johnson and Johnson  13.30 %
Amgen Inc   13.08 %
Medinotec Inc   13.06 %
Lantheus Holdings Inc   13.02 %
Msa Safety Inc  13.02 %
Universal Health Services Inc   12.43 %
Ufp Technologies Inc   12.12 %
Solventum Corporation  11.98 %
Ligand Pharmaceuticals Incorporated  11.93 %
Lifevantage Corp  11.84 %
Regeneron Pharmaceuticals Inc   11.83 %
Protagonist Therapeutics inc   11.66 %
Encompass Health Corporation  11.56 %
Embecta Corp   11.20 %
Lemaitre Vascular Inc   11.20 %
3m Company  11.16 %
Globus Medical Inc   11.01 %

Date modified: 2026-09-26T07:42:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.